Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination.

Autor: Cheng, Samuel M.S.1 (AUTHOR), Mok, Chris K.P.2,3,4 (AUTHOR), Li, John K.C.1 (AUTHOR), Chan, Ken K.P.5 (AUTHOR), Luk, Kristine S.6 (AUTHOR), Lee, Ben H.W.1 (AUTHOR), Gu, Haogao1 (AUTHOR), Chan, Karl C.K.1 (AUTHOR), Tsang, Leo C.H.1 (AUTHOR), Yiu, Karen Y.S.5 (AUTHOR), Ling, Ken K.C.5 (AUTHOR), Tang, Yun Sang2,3 (AUTHOR), Luk, Leo L.H.1 (AUTHOR), Yu, Jennifer K.M.1 (AUTHOR), Pekosz, Andrew7 (AUTHOR), Webby, Richard J.8 (AUTHOR), Cowling, Benjamin J.1 (AUTHOR), Hui, David S.C.4,5 (AUTHOR), Peiris, Malik1,9 (AUTHOR) malik@hku.hk
Zdroj: Virology Journal. 3/21/2024, Vol. 21 Issue 1, p1-7. 7p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje